Virology Journal
病毒学杂志
ISSN: 1743-422X
自引率: 3.7%
发文量: 162
被引量: 7116
影响因子: 5.907
通过率: 暂无数据
出版周期: 不定期刊
审稿周期: 2.71
审稿费用: 0
版面费用: 暂无数据
年文章数: 162
国人发稿量: 68

投稿须知/期刊简介:

Published by BioMed Central. ISSN: 1743-422X.<br>Aims and scope Virology Journal&nbsp;is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies. The Editorial policy of&nbsp;Virology Journal&nbsp;is to publish all research which is assessed by peer reviewers to be a coherent and sound addition to the scientific literature, and puts less emphasis on interest levels or perceived impact. Virology Journal&nbsp;will feature articles on human, animal, plant, insect, bacterial, and fungal viruses. The journal will also publish articles on molecular aspects of the control and prevention of viral infections with vaccines and antiviral agents and on the use of viruses as gene therapy vectors, as well as research on other agents such as prions. The approaches and techniques used are expected to encompass many disciplines, including molecular genetics, molecular biology, biochemistry, biophysics, structural biology, cell biology, immunology, morphology, genetics and pathogenesis.Policy on viral sequencesVirology Journal&nbsp;welcomes the submission of substantive sequences derived from new viruses, substantive sequences associated with important outbreaks in humans, animals or plants or those that contain important polymorphisms, such as clinically relevant mutations that affect drug resistance or changes in receptor binding or those that inform us about basic aspects of virus replication or disease, as well as next generation sequencing data such as viromes. However, the journal will not normally consider short sequences or sequences which are identical or highly related to those seen previously, nor will it publish sequences that are new only by definition of geographical location (e.g. the first description of a particular strain in a certain region), unless there is a clear public health implication of this finding. Such incremental reports can be submitted to our sister journal,&nbsp;Hereditas.Article-processing chargesOpen access publishing is not without costs.&nbsp;Virology Journal&nbsp;therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the submitting author''s institution is a&nbsp;Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are&nbsp;Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from&nbsp;low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our&nbsp;article-processing charge page.Open accessAll articles published by&nbsp;Virology Journal&nbsp;are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found&nbsp;here.As authors of articles published in&nbsp;Virology Journal&nbsp;you are the&nbsp;copyright holders&nbsp;of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the&nbsp;BioMed Central license agreement.For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please&nbsp;contact us&nbsp;if further information is needed.

期刊描述简介:

Aims and scope Virology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies. The Editorial policy of Virology Journal is to publish all research which is assessed by peer reviewers to be a coherent and sound addition to the scientific literature, and puts less emphasis on interest levels or perceived impact. Virology Journal will feature articles on human, animal, plant, insect, bacterial, and fungal viruses. The journal will also publish articles on molecular aspects of the control and prevention of viral infections with vaccines and antiviral agents and on the use of viruses as gene therapy vectors, as well as research on other agents such as prions. The approaches and techniques used are expected to encompass many disciplines, including molecular genetics, molecular biology, biochemistry, biophysics, structural biology, cell biology, immunology, morphology, genetics and pathogenesis. Policy on viral sequences Virology Journal welcomes the submission of substantive sequences derived from new viruses, substantive sequences associated with important outbreaks in humans, animals or plants or those that contain important polymorphisms, such as clinically relevant mutations that affect drug resistance or changes in receptor binding or those that inform us about basic aspects of virus replication or disease, as well as next generation sequencing data such as viromes. However, the journal will not normally consider short sequences or sequences which are identical or highly related to those seen previously, nor will it publish sequences that are new only by definition of geographical location (e.g. the first description of a particular strain in a certain region), unless there is a clear public health implication of this finding. Such incremental reports can be submitted to our sister journal, Hereditas. Article-processing charges Open access publishing is not without costs. Virology Journal therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the submitting author''s institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page. Open access All articles published by Virology Journal are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. As authors of articles published in Virology Journal you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement. For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

最新论文
统计分析
是否有问题?您可以直接对期刊官方提问 提问

最近浏览

关于我们

zlive学术集成海量学术资源,融合人工智能、深度学习、大数据分析等技术,为科研工作者提供全面快捷的学术服务。在这里我们不忘初心,砥砺前行。

友情链接

联系我们

合作与服务

©2024 zlive学术声明使用前必读